vs
ALUMIS INC.（ALMS）与Roivant Sciences Ltd.（ROIV）财务数据对比。点击上方公司名可切换其他公司
ALUMIS INC.的季度营收约是Roivant Sciences Ltd.的1.3倍（$2.7M vs $2.0M），ALUMIS INC.净利率更高（2225.1% vs -13301.2%，领先15526.3%），ALUMIS INC.自由现金流更多（$-107.0M vs $-201.4M）
ALUMIS INC.是一家临床阶段生物制药企业，专注于研发针对自身免疫性疾病与炎症性疾病的创新靶向疗法，旗下多款核心候选产品处于临床试验阶段，致力于满足全球患者尚未被满足的医疗需求。
Roivant Sciences Ltd.是一家美国跨国医疗健康企业，2014年由维韦克·拉马斯瓦米创立，现任CEO为马特·格林。公司专注于将技术应用于药物研发领域，同时孵化运营多家生命科学与健康科技子公司，总部位于纽约，在波士顿、巴塞尔两大生物科技产业集群也设有核心办公点。
ALMS vs ROIV — 直观对比
营收规模更大
ALMS
是对方的1.3倍
$2.0M
净利率更高
ALMS
高出15526.3%
-13301.2%
自由现金流更多
ALMS
多$94.5M
$-201.4M
损益表 — Q2 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.7M | $2.0M |
| 净利润 | $59.3M | $-265.9M |
| 毛利率 | — | — |
| 营业利润率 | -5271.5% | -16966.1% |
| 净利率 | 2225.1% | -13301.2% |
| 营收同比 | — | -77.8% |
| 净利润同比 | 205.0% | -257.0% |
| 每股收益（稀释后） | $0.77 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALMSROIV
| Q4 25 | — | $2.0M | ||
| Q3 25 | — | $1.6M | ||
| Q2 25 | $2.7M | $2.2M | ||
| Q1 25 | $17.4M | $-39.6M | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | — | $4.5M | ||
| Q2 24 | — | $8.0M | ||
| Q1 24 | — | $28.9M |
净利润ALMSROIV
| Q4 25 | — | $-265.9M | ||
| Q3 25 | — | $-113.5M | ||
| Q2 25 | $59.3M | $-223.4M | ||
| Q1 25 | $-99.0M | $-206.5M | ||
| Q4 24 | — | $169.4M | ||
| Q3 24 | — | $-230.2M | ||
| Q2 24 | — | $95.3M | ||
| Q1 24 | — | $-151.1M |
营业利润率ALMSROIV
| Q4 25 | — | -16966.1% | ||
| Q3 25 | — | -19492.9% | ||
| Q2 25 | -5271.5% | -13130.0% | ||
| Q1 25 | -583.9% | 674.8% | ||
| Q4 24 | — | -3042.6% | ||
| Q3 24 | — | -7636.0% | ||
| Q2 24 | — | -1279.5% | ||
| Q1 24 | — | -919.5% |
净利率ALMSROIV
| Q4 25 | — | -13301.2% | ||
| Q3 25 | — | -7225.9% | ||
| Q2 25 | 2225.1% | -10292.9% | ||
| Q1 25 | -569.1% | 521.8% | ||
| Q4 24 | — | 1878.3% | ||
| Q3 24 | — | -5143.8% | ||
| Q2 24 | — | 1192.7% | ||
| Q1 24 | — | -522.3% |
每股收益（稀释后）ALMSROIV
| Q4 25 | — | $-0.38 | ||
| Q3 25 | — | $-0.17 | ||
| Q2 25 | $0.77 | $-0.33 | ||
| Q1 25 | $-1.82 | $-0.28 | ||
| Q4 24 | — | $0.23 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $0.12 | ||
| Q1 24 | — | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $486.3M | $4.5B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $485.3M | $4.3B |
| 总资产 | $610.9M | $5.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALMSROIV
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $4.4B | ||
| Q2 25 | $486.3M | $4.5B | ||
| Q1 25 | $208.7M | $4.9B | ||
| Q4 24 | — | $5.1B | ||
| Q3 24 | — | $5.4B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | — | $6.5B |
总债务ALMSROIV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $311.7M | ||
| Q1 24 | — | $430.6M |
股东权益ALMSROIV
| Q4 25 | — | $4.3B | ||
| Q3 25 | — | $4.4B | ||
| Q2 25 | $485.3M | $4.3B | ||
| Q1 25 | $168.3M | $4.7B | ||
| Q4 24 | — | $5.2B | ||
| Q3 24 | — | $5.2B | ||
| Q2 24 | — | $5.4B | ||
| Q1 24 | — | $6.0B |
总资产ALMSROIV
| Q4 25 | — | $5.2B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | $610.9M | $5.0B | ||
| Q1 25 | $261.3M | $5.4B | ||
| Q4 24 | — | $5.8B | ||
| Q3 24 | — | $6.2B | ||
| Q2 24 | — | $6.5B | ||
| Q1 24 | — | $7.2B |
负债/权益比ALMSROIV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-106.4M | $-196.5M |
| 自由现金流经营现金流 - 资本支出 | $-107.0M | $-201.4M |
| 自由现金流率自由现金流/营收 | -4012.3% | -10076.0% |
| 资本支出强度资本支出/营收 | 23.1% | 246.9% |
| 现金转化率经营现金流/净利润 | -1.79× | — |
| 过去12个月自由现金流最近4个季度 | — | $-776.7M |
8季度趋势，按日历期对齐
经营现金流ALMSROIV
| Q4 25 | — | $-196.5M | ||
| Q3 25 | — | $-185.7M | ||
| Q2 25 | $-106.4M | $-204.4M | ||
| Q1 25 | $-80.4M | $-172.6M | ||
| Q4 24 | — | $-207.3M | ||
| Q3 24 | — | $-266.8M | ||
| Q2 24 | — | $-192.8M | ||
| Q1 24 | — | $-108.5M |
自由现金流ALMSROIV
| Q4 25 | — | $-201.4M | ||
| Q3 25 | — | $-193.5M | ||
| Q2 25 | $-107.0M | $-208.4M | ||
| Q1 25 | $-80.4M | $-173.4M | ||
| Q4 24 | — | $-209.1M | ||
| Q3 24 | — | $-267.8M | ||
| Q2 24 | — | $-193.8M | ||
| Q1 24 | — | $-108.8M |
自由现金流率ALMSROIV
| Q4 25 | — | -10076.0% | ||
| Q3 25 | — | -12317.8% | ||
| Q2 25 | -4012.3% | -9604.5% | ||
| Q1 25 | -462.3% | 438.1% | ||
| Q4 24 | — | -2318.5% | ||
| Q3 24 | — | -5984.4% | ||
| Q2 24 | — | -2425.5% | ||
| Q1 24 | — | -376.1% |
资本支出强度ALMSROIV
| Q4 25 | — | 246.9% | ||
| Q3 25 | — | 499.6% | ||
| Q2 25 | 23.1% | 185.9% | ||
| Q1 25 | 0.2% | -2.0% | ||
| Q4 24 | — | 20.3% | ||
| Q3 24 | — | 22.3% | ||
| Q2 24 | — | 12.1% | ||
| Q1 24 | — | 1.2% |
现金转化率ALMSROIV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.79× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -1.22× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.02× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
